To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Thrombolytic drugThrombolytic drugs are used in medicine to dissolve blood clots in a procedure termed thrombolysis. They limit the damage caused by the blockage of the blood vessel. Product highlight
UsesThrombolysis is used in for myocardial infarction (heart attack), ischemic strokes, deep vein thrombosis and pulmonary embolism to clear a blocked artery and avoid permanent damage to the perfused tissue (e.g. myocardium, brain, leg) and death. A less frequent use is to clear blocked catheters that are used in long-term medical therapy. It should be noted that thrombolytic therapy in hemorrhagic strokes is contraindicated, as its use in that situation would prolong bleeding into the intracranial space and cause further damage. MembersThe thrombolytic drugs include:
These drugs are most effective if administered immediately after it has been determined they are clinically appropriate. The advantage of administration is highest within the first ninety minutes, but may extend up to six hours after the start of symptoms. The drugs are often given in combination with intravenous heparin, or low molecular weight heparin, which are anticoagulant drugs. Side-effectsHemorrhagic stroke is a rare but serious complication of thrombolytic therapy. If a patient has had thrombolysis before, an allergy against the thrombolytic drug may have developed (especially after streptokinase). If the symptoms are mild, the infusion is stopped and the patient is commenced on an antihistamine before infusion is recommenced. Anaphylaxis generally requires immediate cessation of thrombolysis. See also
|
|||||||||||||||||||
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Thrombolytic_drug". A list of authors is available in Wikipedia. | |||||||||||||||||||
- Pimarsäure
- Advion, Ltd. - Harlow, Grande-Bretagne
- Modification génétique de cellules individuelles chez les animaux - La méthode simplifie et accélère la recherche sur les animaux et est particulièrement adaptée à l'étude des maladies ayant des causes génétiques complexes : projet d'essaimage
- Light on – light off: the test result is ready - Inspired by nature - Light-controlled bio-based OptoAssays can diagnose diseases more easily and cost-effectively
- A fungus converts cellulose directly into a novel platform chemical - A new process for the mass production of erythro-isocitric acid from waste could make the substance interesting for industry in the future



